By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Agendia BV 

Slotervaart Medical Centre, 9D
Louwesweg 6
Amsterdam    1066 EC  The Netherlands
Phone: 31-20-512-9161 Fax: 31-20-512-9162


SEARCH JOBS


Industry
Services
Healthcare






Company News
Agendia BV Announces Recommendation Of MammaPrint In Germany’s AGO Guidelines, At St. Gallen International Breast Cancer Conference 4/8/2015 10:21:04 AM
Agendia BV Announces Recommendation Of Mammaprint In Germany’s AGO Guidelines, At St. Gallen International Breast Cancer Conference 4/7/2015 10:16:46 AM
Rubicon Genomics, Inc. And Agendia BV Renew Agreement For Use Of TransPLEX Whole Transcriptome RNA Amplification Kits With MammaPrint FFPE Breast Cancer Test 4/7/2015 6:29:12 AM
Agendia BV Receives New FDA Clearance for MammaPrint FFPE Breast Cancer Test 2/10/2015 6:21:04 AM
Agendia BV Appoints Jan Egberts, M.D., As CEO 10/2/2014 6:06:47 AM
Agendia BV Announces Study Showing Molecular Subtyping Can Improve Breast Cancer Treatment 9/16/2014 8:57:23 AM
Agendia BV Test For Molecular Subtyping Of Breast Cancer Is A Better Guide To Pre-Surgical Treatment, Study Finds 9/15/2014 10:45:28 AM
Agendia BV Announces Study Showing Molecular Subtyping Can Improve Breast Cancer Treatment 9/2/2014 11:05:49 AM
Agendia BV Co-Founder And CSO Develops Method To Identify Women Who Will Benefit From Tamoxifen Therapy For Breast Cancer 7/31/2014 10:59:07 AM
Agendia BV And CBLpath Announce Agreement To Assist Physicians In Diagnostic Assessment Of Breast Cancer 7/16/2014 8:39:05 AM
12345678910
//-->